Guzel, E.;                     Hanta, I.;                     Baydar Toprak, O.;                     Gurbuz, O.;                     Mete, B.;                     Bayram, E.    
        Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors. Medicina 2025, 61, 1258.
    https://doi.org/10.3390/medicina61071258
    AMA Style
    
                                Guzel E,                                 Hanta I,                                 Baydar Toprak O,                                 Gurbuz O,                                 Mete B,                                 Bayram E.        
                Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors. Medicina. 2025; 61(7):1258.
        https://doi.org/10.3390/medicina61071258
    
    Chicago/Turabian Style
    
                                Guzel, Efraim,                                 Ismail Hanta,                                 Oya Baydar Toprak,                                 Okan Gurbuz,                                 Burak Mete,                                 and Ertugrul Bayram.        
                2025. "Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors" Medicina 61, no. 7: 1258.
        https://doi.org/10.3390/medicina61071258
    
    APA Style
    
                                Guzel, E.,                                 Hanta, I.,                                 Baydar Toprak, O.,                                 Gurbuz, O.,                                 Mete, B.,                                 & Bayram, E.        
        
        (2025). Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors. Medicina, 61(7), 1258.
        https://doi.org/10.3390/medicina61071258